Table 2.
Characteristics of those who completed the global health status/QoL at 12 months and those who did not complete the global health status/QoL scale at 12 months
| Characteristics | No global health status/QoL at 12 months, N = 34 (%) | Global health status/QoL at 12 months, N = 78 (%) |
| Median age at baseline (interquartile range) | 74.6 (70.9, 78.5) | 73.8 (69.1, 77.6) |
| Sex % women | 20 (58.8) | 58 (74.4) |
| Born in Canada | 22 (64.7) | 43 (55.1) |
| Married/common law | 21 (61.8) | 41 (52.6) |
| Level of education | ||
| 0–4 years | 1 (2.9) | 4 (5.1) |
| 5–8 years | 6 (17.6) | 13 (16.7) |
| 9–12 years | 13 (38.2) | 28 (35.9) |
| ≥13 years | 14 (41.2) | 33 (42.3) |
| Living alone | 14 (41.2) | 31 (39.7) |
| Social support available | 26 (76.5) | 56 (71.8) |
| Cancer diagnosis | ||
| Lung | 12 (35.3) | 15 (19.2)* |
| Breast | 4 (11.8) | 40 (51.3) |
| Colorectal | 7 (20.6) | 14 (17.9) |
| Hematological malignancy | 11 (32.4) | 9 (11.5) |
| Cancer diagnosis is: | ||
| First cancer diagnosis | 32 (94.1) | 68 (87.2) |
| Recurrence | 0 | 2 (2.6) |
| New diagnosis, has been diagnosed in the past | 2 (5.9) | 8 (10.3) |
| Advanced stage of disease (stage 3–4) | 23 (67.6) | 26 (33.3)* |
| Extensive treatment received | 15 (44.1) | 30 (38.5) |
| Median number of comorbid conditions at baseline (interquartile range) | 2.0 (1, 4) | 2.0 (1, 3) |
| ECOG PS at baseline | ||
| 0 | 14 (41.2) | 58 (74.4)* |
| 1 | 10 (29.4) | 12 (15.4) |
| ≥2 | 10 (29.4) | 8 (10.3) |
| Presence of functional limitations at baseline | 16 (47.1) | 22 (28.2) |
| Presence of IADL disability at baseline | 17 (50.0) | 22 (28.2)* |
| Presence of ADL disability at baseline | 6 (17.6) | 6 (7.7) |
| Presence of mood disturbance at baseline | 9 (30.0) | 17 (22.1) |
| EORTC QLQ-C30 scores | ||
| Global health status/QoL (interquartile range)a | 66.7 (5, 83.3) | 66.7 (58.3, 83.3) |
| Functional scalesa | ||
| Emotional functioning (interquartile range) | 75 (52.1, 89.6) | 83.3 (66.7, 91.7) |
| Physical functioning (Interquartile range) | 80 (55, 93.3) | 93.3 (76.7, 100)* |
| Role functioning (interquartile range) | 100 (66.7, 100) | 100 (83.3, 100) |
| Cognitive functioning (interquartile range) | 83.3 (66.7, 100) | 100 (83.3, 100) |
| Social functioning (interquartile range) | 100 (66.7, 100) | 100 (83.3, 100) |
| Symptom scalesb | ||
| Fatigue (interquartile range) | 22.2 (0, 55.6) | 22.2 (11.1, 33.3) |
| Nausea–vomiting (interquartile range) | 0 (0, 16.7) | 0 (0, 0)* |
| Pain (interquartile range) | 16.7 (0, 50) | 16.7 (0, 16.7) |
| Dyspnea (interquartile range) | 0 (0, 33.3) | 0 (0, 33.3) |
| Insomnia (interquartile range) | 33.3 (8.3, 66.7) | 33.3 (0, 33.3) |
| Appetite loss (interquartile range) | 0 (0, 33.3) | 0 (0, 33.3) |
| Constipation (interquartile range) | 0 (0, 33.3) | 0 (0, 0) |
| Diarrhea (interquartile range) | 0 (0, 0) | 0 (0, 0) |
| Financial problems (interquartile range) | 0 (0, 0) | 0 (0, 0) |
ADL, activities of daily living; ECOG PS, Eastern Cooperative Oncology Group performance status; EORTC QLQ-C30, European Organization for the Research and Treatment of Cancer Quality of Life Core Questionnaire with 30 items; IADL, instrumental activities of daily living; QoL, quality of life.
a
For the global health status/QoL and functional scales, 0 = poor functioning and 100 = highest level of functioning.
b
Symptom scales 0 = no symptoms and 100 = maximum symptomatology.
*
P < 0.05.